IRF4 and bronchopulmonary dysplasia: Knockout of IRF4 can inhibit the FOXP3+Tregs phenotype to FOXP3+RORγt+Tregs phenotype, reduce lung tissue inflammation, and promote alveolar development, which may provide a new strategy for treating BPD.